102 related articles for article (PubMed ID: 14755681)
1. Par-4 inducible apoptosis in prostate cancer cells.
Gurumurthy S; Rangnekar VM
J Cell Biochem; 2004 Feb; 91(3):504-12. PubMed ID: 14755681
[TBL] [Abstract][Full Text] [Related]
2. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4.
Qiu G; Ahmed M; Sells SF; Mohiuddin M; Weinstein MH; Rangnekar VM
Oncogene; 1999 Jan; 18(3):623-31. PubMed ID: 9989812
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cancer cell survival by Par-4.
Ranganathan P; Rangnekar VM
Ann N Y Acad Sci; 2005 Nov; 1059():76-85. PubMed ID: 16382046
[TBL] [Abstract][Full Text] [Related]
4. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
Vetterkind S; Boosen M; Scheidtmann KH; Preuss U
Int J Oncol; 2005 Jan; 26(1):159-67. PubMed ID: 15586236
[TBL] [Abstract][Full Text] [Related]
5. Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.
Kukoc-Zivojnov N; Puccetti E; Chow KU; Bergmann M; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E; Boehrer S
Exp Hematol; 2004 Jul; 32(7):649-56. PubMed ID: 15246161
[TBL] [Abstract][Full Text] [Related]
6. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells.
Srinivasan S; Ranga RS; Burikhanov R; Han SS; Chendil D
Cancer Res; 2007 Jan; 67(1):246-53. PubMed ID: 17185378
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of the proapoptotic protein Par-4 in normal rat tissues.
Boghaert ER; Sells SF; Walid AJ; Malone P; Williams NM; Weinstein MH; Strange R; Rangnekar VM
Cell Growth Differ; 1997 Aug; 8(8):881-90. PubMed ID: 9269897
[TBL] [Abstract][Full Text] [Related]
8. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
Brieger A; Boehrer S; Schaaf S; Nowak D; Ruthardt M; Kim SZ; Atadja P; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Biochem Pharmacol; 2004 Jul; 68(1):85-93. PubMed ID: 15183120
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
10. Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis.
Bergmann M; Kukoc-Zivojnov N; Chow KU; Trepohl B; Hoelzer D; Weidmann E; Mitrou PS; Boehrer S
Ann Hematol; 2004 Oct; 83(10):646-53. PubMed ID: 15316756
[TBL] [Abstract][Full Text] [Related]
11. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
12. Differential control of apoptosis by DJ-1 in prostate benign and cancer cells.
Hod Y
J Cell Biochem; 2004 Aug; 92(6):1221-33. PubMed ID: 15258905
[TBL] [Abstract][Full Text] [Related]
13. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
Ye L; Kynaston H; Jiang WG
Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.
Li T; Li D; Sha J; Sun P; Huang Y
Biochem Biophys Res Commun; 2009 Jun; 383(3):280-5. PubMed ID: 19302977
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma.
Cook J; Krishnan S; Ananth S; Sells SF; Shi Y; Walther MM; Linehan WM; Sukhatme VP; Weinstein MH; Rangnekar VM
Oncogene; 1999 Feb; 18(5):1205-8. PubMed ID: 10022126
[TBL] [Abstract][Full Text] [Related]
17. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer.
Zhang X; Jin TG; Yang H; DeWolf WC; Khosravi-Far R; Olumi AF
Cancer Res; 2004 Oct; 64(19):7086-91. PubMed ID: 15466204
[TBL] [Abstract][Full Text] [Related]
18. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
Kang J; Bu J; Hao Y; Chen F
Prostate Cancer Prostatic Dis; 2005; 8(3):274-9. PubMed ID: 15897917
[TBL] [Abstract][Full Text] [Related]
19. Protein expression and intracellular localization of prostate apoptosis response-4 (Par-4) are associated with apoptosis induction in nasopharyngeal carcinoma cell lines.
Lee JW; Lee KF; Hsu HY; Hsu LP; Shih WL; Chu YC; Hsiao WT; Liu PF
Cancer Lett; 2007 Nov; 257(2):252-62. PubMed ID: 17881119
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria from TRAIL-resistant prostate cancer cells are capable of responding to apoptotic stimuli.
Liang Y; Eid MA; Lewis RW; Kumar MV
Cell Signal; 2005 Feb; 17(2):243-51. PubMed ID: 15494215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
